Matthew Caufield
Stock Analyst at HC Wainwright & Co.
(0)
# 5027
Out of 5,297 analysts
139
Total ratings
19.05%
Success rate
-37.88%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MLYS Mineralys Therapeuti... | Maintains: Strong Buy | 30 42 | 13.76 | 205.23% | 7 | Apr 2, 2025 | |
SRZN Surrozen | Reiterates: Buy | 32 32 | 11.86 | 169.81% | 2 | Apr 2, 2025 | |
FBLG FibroBiologics | Reiterates: Buy | 12 12 | 0.91 | 1218.68% | 4 | Apr 1, 2025 | |
IRD Opus Genetics | Reiterates: Buy | 8 8 | 0.94 | 751.06% | 3 | Apr 1, 2025 | |
HLVX HilleVax | Reiterates: Neutral | 2 2 | 1.45 | 37.93% | 6 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 3 3 | 2.44 | 22.95% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 12 2 | 3.41 | -41.35% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 4 | 1.01 | 296.04% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 1.12 | 78.57% | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 18 9 | 9.11 | -1.21% | 7 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 3.65 | 173.97% | 4 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 0.1 | 1900% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 7.95 | 277.36% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 28 | 5.17 | 441.59% | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.54 | 549.35% | 11 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 36 36 | 3 | 1100% | 18 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.03 | 870.87% | 2 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 3.81 | 687.4% | 4 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 38 38 | 23.3 | 63.09% | 3 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 18 | n/a | n/a | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 | 170.4 | -83.57% | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 40 | n/a | n/a | 6 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Jul 18, 2022 |